The membrane expression of PD-1 and PD-L1 is crucial to cancer immunotherapy, although in some cases there is little or no significant difference in overall survival between patients with PD-L1-positive and PD-L1-negative tumors [7]. The gene discussed is CD274; the disease is cancer.